MedTrace Logo

Practice of Assisted Vaginal Birth in Egypt

NCT07308977 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-05-12

No results posted yet for this study

Summary

In Egypt, the proportion of CSs has been steadily increasing in recent years and has reached an alarming level. According to data from the Royal College of Obstetricians and Gynaecologists (RCOG), approximately 6% of caesarean sections (CS) are performed on average because of inadequate supervision from junior staff members or a lack of training, particularly during the critical decision-making phase of this second stage. The unfamiliarity and lack of experience with operative vaginal delivery is a major cause for the rise in the rate of second stage caesarean section. This survey targets obstetricians with different levels of experience to find practical solutions to increase the rate of assisted vaginal delivery which subsequently will decrease the rate of second stage CS.

Conditions

  • Vaginal Delivery

Interventions

OTHER

Survey using a questionnaire.

This cross-sectional study aims to identify the obstacles preventing an increase in AVB performance in Egypt. Obstetricians from three tertiary care centers in Egypt will be invited to participate in this Online web-based survey over the study period. The questions in this survey are included in 5 sections; demographics, workload and AVB practice, obstetrician-related factors, service provision factors, and what changes could be implemented to increase the rate of uptake of AVB by Egyptian obstetricians. The link to the survey will be sent to the study participants, and the data will be collected for analysis

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Alaa S Elsewafy, M.D., · Faculty of Medicine - Ain Shams university

  • Mohamed A Haroun · Faculty of Medicine - Modern University for Technology and Information

  • Ahmed M Sweidan · Faculty of Medicine - Suez University

Eligibility

Min Age
28 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-07-15
Completion
2026-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07308977 on ClinicalTrials.gov